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Summary
A 62-year-old male with pulmonary fibrosis and aortic 
valve stenosis underwent TAVI (Corevalve Evolut XL 
34 mm) in the build-up for lung transplantation (LuTx). 
Following post-dilation for a large annular perimeter, 
moderate paravalvular aortic regurgitation (AR) was 
observed (Video 1). After 6 weeks, he was admitted to the 
ICU with respiratory failure (Fig. 1A). TTE demonstrated 
residual mild AR (based on a small excentric paravalvular 
AR jet, <10% circumferential extent, pressure half-time 
was not reliably measured) and together with borderline 
elevated NT-pro-BNP, the consultant cardiologist 
authorized LuTx listing.
However, an abnormal radial arterial pressure waveform 
was noticed (Fig. 1B). Femoral artery Doppler ultrasound 
demonstrated holo-diastolic backflow (Duroziez’s sign, 
Fig. 1C), which may indicate severe AR. Repeat biplane TTE 
confirmed 30% circumferential paravalvular AR (Fig. 1D, 
Videos 2 and 3) and descending aorta end-diastolic flow 
reversal >20 cm/s (Fig. 1E), consistent with the diagnosis.
The patient deteriorated rapidly. Given the shortage of donor 
organs, the option of LuTx after ECMO-assisted paravalvular 
leak closure (with unpredictable result) was deemed 
inappropriate. He died and autopsy was done (Fig. 1F).
Assessment of the severity of AR after TAVI is challenging. 
Determination of the circumferential extent of 
paravalvular AR assessed by TTE is regarded ‘critical’, but 
may be difficult (1, 2, 3, 4). Although transoesophageal 
echocardiography may be the default technique in case 
of uncertainty, this was impossible since this would 
have required mechanical ventilation, which can be 
very challenging in end-stage pulmonary fibrosis. In 
conclusion, clinical signs together with all possible 
echocardiography views are paramount for the diagnosis.
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Video 1
Aortography at the time of the procedure, showing 
grade 3 aortic regurgitatation. View Video 1 at http://
movie-usa.glencoesoftware.com/video/10.1530/ERP-17-
0041/video-1.
Video 3
Parasternal biplane view, colour-Doppler, showing 
paravalvular aortic regurgitation. View Video 3 at http://
movie-usa.glencoesoftware.com/video/10.1530/ERP-17-
0041/video-3.
Video 2
Parasternal long-axis view showing paravalvular aortic 
regurgitation through colour-Doppler at the TAVI stent 
inflow level. View Video 2 at http://movie-usa.
glencoesoftware.com/video/10.1530/ERP-17-0041/video-2.
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Figure 1
(A) Chest X-ray, reticular shadowing of lung parenchyma and pleural fluid; (B) Radial arterial pressure waveform, rapid upstroke, diminished dicrotic 
notch and wide pulse pressure (200/50 mmHg); (C) Doppler ultrasound of femoral artery, holo-diastolic flow reversal; (D) TTE, parasternal short-axis view, 
paravalvular AR; (E) TTE, suprasternal long-axis view of descending aorta, holo-diastolic flow reversal; (F) PA specimen of the TAVI seen from the 
ascending aorta, where a probe indicates the leak.
